News

News

Kagocel wins the Smartpharma Awards for the third time
22.04.2021 17:32:00

The antiviral drug "Kagocel" has again been recognized as No. 1 antiviral agent against influenza and ARVI for adults and children from 3 years of age. The drug wins in this category for the third year in a row.

Detail
Kagocel Becomes Official Sponsor of the 2021 ISU World Figure Skating Championships
19.03.2021 21:27:00

The antiviral drug Kagocel once again provides sponsorship for the organization and holding of a competition in one of the most beautiful and spectacular sports: from March 22 through March 28, the ISU World Figure Skating Championships will be held in Stockholm.

Detail
Kagocel to sponsor the ISU European Figure Skating Championships in 2022
26.02.2021 03:32:00

The antiviral drug Kagocel will continue to support figure skating competitions, despite the cancellation of the ISU European Championships in 2021 due to the Covid-19 pandemic.

Detail
Kagocel to Sponsor the Russian Figure Skating Cup Finals
26.02.2021 03:06:00

The antiviral drug Kagocel continues to support figure skating competitions, and, and will sponsor the final stage of the Russian Cup competitions.

Detail
Data of five studies on Kagocel are available in the ClinicalTrials.gov international database
13.01.2021 18:06:00

The results of two more studies on the Russian antiviral drug Kagocel have recently been published in the international clinical trial database ClinicalTrials.gov.

Detail
Kagocel wins Russian Pharma Awards again
22.12.2020 14:27:00

On December 16, the antiviral drug Kagocel was for the seventh time proclaimed winner of the annual Russian Pharma Awards in the category "Antiviral agent No. 1 in Russia against influenza and ARVI for adults and children from the age of three".

Detail
Nearmedic Group supports doctors in the season of colds
17.12.2020 12:38:00

The Nearmedic group of companies has realized a large-scale charity event by passing the antiviral drug Kagocel over to the country's medical institutions.

Detail
Kagocel wins the Choice of the Year contest in Belarus again
15.12.2020 19:16:00

Kagocel wins the Choice of the Year contest in Belarus again.

Detail
Brand Kagocel creative work receives a pharmaceutical marketing award
02.12.2020 23:33:00

The commercial Family Law created by the marketing team of the antiviral brand Kagocel, won silver at the MedMen Healthcare Creative Awards.

Detail
Two studies of the drug Kagocel have been included in the international database of clinical trials ClinicalTrials.gov
27.11.2020 13:42:00

Results of two post-registration clinical trials of the antiviral drug Kagocel effectiveness were published in the international database of clinical trials ClinicalTrials.gov.

Detail
Nearmedic Pharma defends Kagocel's reputation in court
17.11.2020 12:00:00

On November 12, 2020, the Arbitration Court of the city of Saint Petersburg and the Leningrad region satisfied the claim of Nearmedic Pharma LLC to protect its business reputation. The claim was induced by the material made public on 28.01.2020 in Doctor Peter online magazine and containing untrue information about the composition and non-existent side effects of the company's antiviral drug Kagocel.

Detail
Learn to make money on offline purchases and get a 15% cashback on Kagocel
05.11.2020 17:49:00

The Nearmedic Pharma company has launched a cashback program for the popular antiviral drug Kagocel. The promotion program has been developed in collaboration with the Wavemaker advertising agency.

Detail
Kagocel to become the official sponsor of the 2021 ISU European and World Figure Skating Championships
24.07.2020 17:00:00

The antiviral drug Kagocel will once again become the official sponsor of the ISU European Figure Skating Championships® and ISU World Figure Skating Championships® to be held in 2021. The brand has been supporting those sports events since 2018.

Detail
Kagocel again recognized as No. 1 antiviral agent by Smartpharma Awards
03.07.2020 16:57:00

For the second year in a row, Kagocel was recognized by Smartpharma Awards 2020 as the best influenza and ARVI antiviral agent in Russia for adults and children from 3 years old. The award ceremony was held in a solemn atmosphere, but with all the necessary precautions related to the new coronavirus pandemic.

Detail
In vitro studies demonstrate high antiviral activity of Kagocel against COVID-19
19.06.2020 16:57:00

The 48th Central Research Institute of the Russian Federation Ministry of Defense (CRI 48) has studied the antiviral activity of the drug Kagocel in relation to a new pandemic strain of SARS-CoV-2 in the course of in vitro experiments.

Detail
Disclosure of information about the safety of the Kagocel® antiviral drug
06.02.2020 11:22:00

Recently, social networks and a number of media outlets have been ever more frequently spreading knowingly false and absurd speculations about the composition, non-core properties and non-existent side effects, as well as adverse effects associated with the Kagocel® antiviral drug.

Detail
Kagocel to Officially Sponsor the 2020 ISU World and European Figure Skating Championships®
27.06.2019 12:33:00

The antiviral brand Kagocel keeps up the tradition of supporting sports events.

Detail
Nearmedic Awarded for Innovative Approach in Cross-Media Advertising
04.06.2019 12:33:00

In the framework of the Smartpharma Awards 2019, the Gazprom-Media sales house, title partner of the award, gave Nearmedic  a special award "For innovative approach in cross-media advertising", thus praising marketing activities of the company's brand Kagocel.

Detail
Smartpharma® Awards 2019: Kagocel Is No.1 Remedy Against SARS and Flu
03.06.2019 12:30:00

On May 22, 2019 Kagocel was recognized as the best drug in the nomination "Antiviral agent No.1 in Russia against influenza and SARS in adults and children from 3 years" according to Smartpharma® Awards 2019.  

Detail
Brand Kagocel's Initiatives Praised by Best Social Projects of Russia Program
21.05.2019 12:25:00

On May 24, 2019, the ceremony of awarding the participants of the program "Best social projects of Russia" was held.

Detail

OUR AWARDS